Bruker (BRKR) Financials

$38.13 -1.84 (-4.59%)

As of 03:27 PM Eastern

Annual Income Statements for Bruker

This table shows Bruker's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	102	154	79	180	197	158	277	297	427	113
Consolidated Net Income / (Loss)	105	155	80	181	198	161	281	299	429	114
Net Income / (Loss) Continuing Operations	105	155	80	181	499	161	281	299	429	114
Total Pre-Tax Income	128	178	198	245	280	226	394	414	544	207
Total Operating Income	146	182	220	262	301	248	413	433	437	253
Total Gross Profit	709	745	816	900	995	940	1,210	1,306	1,513	1,650
Total Revenue	1,624	1,611	1,766	1,896	4,145	1,988	2,418	2,531	2,965	3,366
Operating Revenue	1,617	1,611	1,766	1,896	4,145	1,988	2,418	2,531	2,965	3,366
Total Cost of Revenue	915	866	950	996	2,155	1,048	1,208	1,225	1,451	1,717
Operating Cost of Revenue	915	866	950	996	2,155	-	1,208	1,225	1,451	1,717
Total Operating Expenses	563	564	597	638	1,389	692	796	873	1,076	1,396
Selling, General & Admin Expense	392	390	415	445	500	469	561	607	729	894
Research & Development Expense	146	148	162	173	188	198	221	236	295	377
Other Special Charges / (Income)	25	26	20	20	6.50	25	14	30	52	126
Total Other Income / (Expense), net	-18	-4.20	-22	-18	-21	-23	-20	-19	107	-46
Other Income / (Expense), net	-18	-4.20	-22	-18	-21	-23	-20	-19	107	-46
Income Tax Expense	23	23	118	64	82	64	113	116	118	91
Other Gains / (Losses), net	-	-	-	-	-	0.00	0.00	1.00	2.00	-1.70
Net Income / (Loss) Attributable to Noncontrolling Interest	3.30	0.90	1.70	1.30	0.80	3.60	3.50	1.90	1.30	0.70
Basic Earnings per Share	$0.60	$0.95	$0.50	$1.15	$1.27	$1.03	$1.83	$2.00	$2.92	$0.76
Weighted Average Basic Shares Outstanding	168.20M	161.40M	158.10M	156.20M	155.20M	153.40M	151.40M	148.60M	146.40M	149M
Diluted Earnings per Share	$0.60	$0.95	$0.49	$1.14	$1.26	$1.02	$1.81	$1.99	$2.90	$0.76
Weighted Average Diluted Shares Outstanding	169.10M	162.20M	159.10M	157.20M	156.60M	154.60M	152.90M	149.40M	147.20M	149.50M
Weighted Average Basic & Diluted Shares Outstanding	169.30M	161.70M	157.20M	156.30M	155.30M	151.57M	150.77M	146.73M	137.67M	151.71M
Cash Dividends to Common per Share	-	$0.16	$0.00	$0.00	$300,000.00	$0.16	$0.16	$0.20	$0.20	$0.20

This table shows Bruker's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	88	97	77	57	88	206	51	7.60	41	14
Consolidated Net Income / (Loss)	88	98	77	58	89	205	52	7.60	40	14
Net Income / (Loss) Continuing Operations	88	98	77	58	89	205	52	7.60	40	14
Total Pre-Tax Income	129	121	107	78	119	241	72	24	55	56
Total Operating Income	131	131	123	86	125	104	65	48	68	72
Total Gross Profit	335	366	360	341	383	430	353	385	419	493
Total Revenue	639	708	685	682	743	855	722	801	864	980
Operating Revenue	639	708	685	682	743	855	722	801	864	980
Total Cost of Revenue	304	343	326	341	360	424	369	416	446	486
Operating Cost of Revenue	304	-	326	341	360	424	369	416	446	486
Total Operating Expenses	204	235	237	254	258	327	288	337	351	421
Selling, General & Admin Expense	145	165	163	178	178	211	195	221	230	247
Research & Development Expense	56	64	69	71	71	84	82	92	98	104
Other Special Charges / (Income)	3.00	6.70	5.30	5.40	9.40	32	11	23	23	70
Total Other Income / (Expense), net	-2.00	-10	-16	-8.70	-5.30	137	6.80	-24	-13	-16
Other Income / (Expense), net	-2.00	-10	-16	-8.70	-5.30	137	6.80	-24	-13	-16
Income Tax Expense	41	23	30	20	31	37	20	16	15	41
Other Gains / (Losses), net	0.30	-	0.70	0.20	0.30	0.80	0.20	-0.20	-0.20	-1.50
Net Income / (Loss) Attributable to Noncontrolling Interest	0.30	0.90	0.90	0.70	0.60	-0.90	1.10	0.00	-0.60	0.20
Basic Earnings per Share	$0.60	$0.66	$0.52	$0.39	$0.60	$1.41	$0.35	$0.05	$0.27	$0.09
Weighted Average Basic Shares Outstanding	147.80M	148.60M	146.80M	146.80M	146.60M	146.40M	145.20M	147.40M	151.50M	149M
Diluted Earnings per Share	$0.59	$0.66	$0.52	$0.39	$0.60	$1.39	$0.35	$0.05	$0.27	$0.09
Weighted Average Diluted Shares Outstanding	148.60M	149.40M	147.60M	147.70M	147.30M	147.20M	145.90M	148M	152M	149.50M
Weighted Average Basic & Diluted Shares Outstanding	147.08M	146.73M	146.73M	146.85M	138.41M	137.67M	145.34M	151.39M	151.60M	151.71M

This table details how cash moves in and out of Bruker's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-54	75	-17	3.90	356	3.60	386	-423	-157	-305
Net Cash From Operating Activities	229	131	154	240	213	332	282	274	350	251
Net Cash From Continuing Operating Activities	229	131	154	240	213	332	282	274	350	251
Net Income / (Loss) Continuing Operations	105	155	80	181	198	161	281	299	429	114
Consolidated Net Income / (Loss)	105	155	80	181	198	161	281	299	429	114
Depreciation Expense	53	54	64	65	76	80	89	89	115	184
Non-Cash Adjustments To Reconcile Net Income	54	34	-5.20	51	20	43	44	46	-81	96
Changes in Operating Assets and Liabilities, net	17	-112	15	-57	-80	47	-131	-159	-112	-142
Net Cash From Investing Activities	-102	-22	-30	-123	-158	-193	-192	-252	-326	-1,757
Net Cash From Continuing Investing Activities	-102	-22	-30	-123	-158	-193	-192	-252	-326	-1,757
Purchase of Property, Plant & Equipment	-34	-37	-44	-49	-73	-97	-92	-129	-107	-115
Acquisitions	-29	-24	-66	-192	-90	-59	-65	-182	-227	-1,600
Purchase of Investments	-159	-127	-119	0.00	-6.40	-151	-149	-60	-25	-48
Sale of Property, Plant & Equipment	0.90	1.10	12	0.40	11	0.20	4.90	14	11	1.10
Sale and/or Maturity of Investments	119	165	187	117	0.00	115	108	106	21	4.80
Net Cash From Financing Activities	-169	-28	-159	-112	300	-162	319	-415	-193	1,230
Net Cash From Continuing Financing Activities	-169	-28	-159	-112	300	-162	319	-415	-193	1,230
Repayment of Debt	-130	-0.10	-151	-223	-386	-305	-0.10	-111	-24	-1,354
Repurchase of Common Equity	-90	-160	-152	0.00	-142	-123	-153	-263	-152	0.00
Payment of Dividends	-1.30	-27	-26	-26	-25	-26	-24	-42	-26	-45
Issuance of Debt	42	146	154	129	849	297	490	0.30	2.00	2,224
Issuance of Common Equity	11	12	20	9.40	11	3.30	7.00	2.80	9.50	409
Other Financing Activities, net	-0.80	1.20	-3.50	-2.30	-6.20	-7.50	-0.40	-2.70	-2.70	-4.70
Effect of Exchange Rate Changes	-11	-6.40	18	-	0.60	26	-23	-31	12	-29
Cash Interest Paid	12	13	15	12	16	29	20	24	34	55
Cash Income Taxes Paid	57	72	53	61	61	43	146	147	97	154

This table details how cash moves in and out of Bruker's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-97	19	-47	-23	-211	125	-148	-170	-22	35
Net Cash From Operating Activities	70	172	88	13	44	206	22	1.10	38	190
Net Cash From Continuing Operating Activities	70	172	88	13	44	206	22	1.10	38	190
Net Income / (Loss) Continuing Operations	88	98	77	58	89	205	52	7.60	40	14
Consolidated Net Income / (Loss)	88	98	77	58	89	205	52	7.60	40	14
Depreciation Expense	21	25	25	26	27	37	35	45	51	53
Non-Cash Adjustments To Reconcile Net Income	13	11	8.60	21	9.40	-121	0.60	27	16	52
Changes in Operating Assets and Liabilities, net	-53	38	-24	-92	-81	84	-66	-79	-69	71
Net Cash From Investing Activities	-58	-149	-108	-26	-155	-37	-304	-1,325	-68	-61
Net Cash From Continuing Investing Activities	-58	-149	-108	-26	-155	-37	-304	-1,325	-68	-61
Purchase of Property, Plant & Equipment	-58	-35	-25	-24	-27	-32	-21	-25	-33	-37
Acquisitions	-0.10	-97	-88	-15	-120	-4.30	-275	-1,302	-0.20	-23
Purchase of Investments	-2.70	-19	-8.20	-1.10	-10	-5.50	-10	-	-36	-2.30
Sale of Property, Plant & Equipment	-	0.10	11	-	0.20	0.20	0.50	0.40	-	0.20
Sale and/or Maturity of Investments	2.90	1.40	2.40	13	1.30	4.30	1.20	1.30	1.20	1.10
Net Cash From Financing Activities	-82	-36	-31	-10	-93	-60	152	1,156	-2.70	-75
Net Cash From Continuing Financing Activities	-82	-36	-31	-10	-93	-60	152	1,156	-2.70	-75
Repayment of Debt	-0.20	-4.80	-2.10	-2.40	-2.50	-17	-109	-848	-155	-243
Payment of Dividends	-11	-8.60	-2.10	-7.60	-8.90	-7.80	-8.20	-7.80	-7.60	-21
Issuance of Debt	-0.10	0.30	0.00	-4.70	-3.40	10	265	805	-3.00	1,157
Issuance of Common Equity	-2.50	2.00	0.70	2.10	2.00	4.70	3.40	405	-2.80	3.20
Other Financing Activities, net	2.30	1.30	-4.80	2.30	-0.20	-	0.00	801	165	-971
Effect of Exchange Rate Changes	-27	33	4.10	0.10	-7.90	16	-18	-2.10	10	-19

This table presents Bruker's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,730	1,808	1,949	2,129	2,772	3,049	3,650	3,612	4,250	5,807
Total Current Assets	1,232	1,276	1,359	1,304	1,796	1,925	2,472	2,113	2,164	2,053
Cash & Equivalents	267	342	325	322	678	682	1,068	646	488	183
Accounts Receivable	235	244	319	357	362	335	417	473	492	566
Inventories, net	422	440	486	510	577	692	710	800	968	1,068
Other Current Assets	107	91	114	115	172	166	177	195	216	237
Plant, Property, & Equipment, net	231	239	267	271	306	396	406	487	600	669
Total Noncurrent Assets	267	293	323	554	669	729	772	1,012	1,486	3,084
Goodwill	131	131	170	276	293	320	340	458	583	1,507
Intangible Assets	75	70	82	219	233	229	212	271	331	913
Noncurrent Deferred & Refundable Income Taxes	53	77	57	51	61	72	90	77	297	286
Other Noncurrent Operating Assets	9.10	17	14	8.40	82	107	131	206	276	378
Total Liabilities & Shareholders' Equity	1,730	1,808	1,949	2,129	2,772	3,049	3,650	3,612	4,250	5,807
Total Liabilities	997	1,115	1,215	1,201	1,833	2,075	2,565	2,480	2,837	3,992
Total Current Liabilities	555	525	525	599	646	792	939	914	1,202	1,281
Short-Term Debt	0.60	20	-	19	0.50	2.20	112	19	121	33
Accounts Payable	72	86	91	105	118	135	147	178	203	234
Current Deferred Revenue	178	149	112	124	138	189	198	370	400	438
Other Current Liabilities	304	270	322	352	389	466	481	347	478	577
Total Noncurrent Liabilities	443	591	691	602	1,188	1,283	1,627	1,566	1,635	2,710
Long-Term Debt	265	392	416	323	813	842	1,222	1,201	1,160	2,062
Noncurrent Deferred Revenue	44	47	49	-	43	51	50	102	92	100
Noncurrent Deferred & Payable Income Tax Liabilities	9.50	10	24	51	49	43	46	62	68	119
Other Noncurrent Operating Liabilities	32	40	96	137	161	223	204	156	315	430
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	23	21	0.00	0.20	6.10	19	18
Total Equity & Noncontrolling Interests	733	693	734	905	917	974	1,085	1,126	1,395	1,797
Total Preferred & Common Equity	726	686	725	897	907	961	1,071	1,114	1,377	1,781
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	726	686	725	897	907	961	1,071	1,114	1,377	1,781
Common Stock	104	126	158	179	201	218	240	258	285	715
Retained Earnings	757	885	942	1,103	1,275	1,407	1,660	1,926	2,324	2,407
Treasury Stock	-91	-249	-401	-402	-544	-667	-820	-1,085	-1,237	-1,237
Accumulated Other Comprehensive Income / (Loss)	-44	-76	27	17	-26	3.70	-8.20	15	6.00	-104
Noncontrolling Interest	6.80	6.70	8.10	8.50	10	13	14	12	17	16

This table presents Bruker's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	3,337	3,764	3,857	3,820	4,506	5,903	6,113
Total Current Assets	2,037	2,133	2,183	2,029	2,140	2,153	2,191
Cash & Equivalents	626	598	575	364	340	170	148
Accounts Receivable	421	472	451	485	475	507	538
Inventories, net	750	859	915	916	1,061	1,176	1,220
Other Current Assets	240	205	243	264	264	300	285
Plant, Property, & Equipment, net	422	511	523	527	586	657	694
Total Noncurrent Assets	879	1,120	1,151	1,263	1,780	3,093	3,228
Goodwill	382	527	558	561	752	1,444	1,475
Intangible Assets	214	299	300	292	449	1,024	1,027
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	280	303	341
Other Noncurrent Operating Assets	283	294	293	410	299	322	386
Total Liabilities & Shareholders' Equity	3,337	3,764	3,857	3,820	4,506	5,903	6,113
Total Liabilities	2,383	2,553	2,594	2,575	3,056	4,078	4,270
Total Current Liabilities	865	1,049	1,051	1,072	1,183	1,305	1,322
Short-Term Debt	17	120	121	121	21	26	33
Accounts Payable	158	196	189	182	199	220	228
Current Deferred Revenue	176	398	397	381	485	502	467
Other Current Liabilities	514	334	344	389	477	556	595
Total Noncurrent Liabilities	1,519	1,505	1,544	1,503	1,873	2,774	2,948
Long-Term Debt	1,137	1,109	1,123	1,099	1,357	2,132	2,265
Noncurrent Deferred Revenue	-	-	-	-	106	94	94
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	82	179	178
Noncurrent Employee Benefit Liabilities	-	-	-	-	76	80	84
Other Noncurrent Operating Liabilities	382	396	421	405	252	290	327
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	5.70	12	12	17	18	18	18
Total Equity & Noncontrolling Interests	948	1,199	1,251	1,227	1,433	1,807	1,825
Total Preferred & Common Equity	937	1,180	1,231	1,209	1,415	1,789	1,807
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	937	1,180	1,231	1,209	1,415	1,789	1,807
Common Stock	1.70	1.70	1.70	1.70	293	703	706
Retained Earnings	-	-	-	-	2,367	2,367	2,401
Treasury Stock	-1,059	-1,107	-1,107	-1,187	-1,237	-1,237	-1,237
Accumulated Other Comprehensive Income / (Loss)	-92	30	24	-5.20	-7.70	-44	-62
Noncontrolling Interest	11	19	20	18	18	18	18

This table displays calculated financial ratios and metrics derived from Bruker's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-10.23%	-0.77%	9.59%	7.34%	118.67%	-52.05%	21.66%	4.67%	17.14%	13.56%
EBITDA Growth	12.61%	27.91%	12.85%	18.30%	14.99%	-13.99%	57.64%	4.14%	31.11%	-40.72%
EBIT Growth	26.36%	38.75%	11.37%	23.71%	14.59%	-19.47%	74.31%	5.16%	31.48%	-61.98%
NOPAT Growth	92.55%	32.45%	-43.66%	117.81%	9.47%	-16.47%	66.01%	5.56%	10.09%	-58.74%
Net Income Growth	76.01%	47.28%	-48.03%	125.40%	9.39%	-18.48%	73.85%	6.38%	43.55%	-73.44%
EPS Growth	81.82%	58.33%	-48.42%	132.65%	10.53%	-19.05%	77.45%	9.94%	45.73%	-73.79%
Operating Cash Flow Growth	100.52%	-42.93%	18.04%	55.25%	-10.97%	55.67%	-14.99%	-2.83%	27.59%	-28.22%
Free Cash Flow Firm Growth	9.48%	-61.48%	-119.38%	-160.32%	317.59%	70.23%	-16.70%	-209.82%	-10.37%	-769.09%
Invested Capital Growth	-15.70%	13.97%	17.44%	33.31%	12.70%	1.91%	15.07%	36.35%	29.38%	68.87%
Revenue Q/Q Growth	-1.80%	-0.49%	3.53%	1.23%	36.46%	-34.21%	2.37%	0.99%	5.18%	3.86%
EBITDA Q/Q Growth	15.99%	10.32%	0.77%	4.21%	3.70%	-0.68%	3.23%	0.60%	25.21%	-30.22%
EBIT Q/Q Growth	22.84%	13.48%	0.10%	4.98%	4.08%	-2.38%	3.63%	0.36%	28.26%	-47.18%
NOPAT Q/Q Growth	50.03%	-1.80%	-43.83%	79.86%	-4.56%	2.03%	1.22%	8.85%	-2.33%	-35.99%
Net Income Q/Q Growth	51.15%	4.82%	-47.31%	80.82%	-4.39%	1.57%	1.70%	8.07%	32.99%	-62.63%
EPS Q/Q Growth	53.85%	7.95%	-47.87%	80.95%	-3.82%	0.00%	2.84%	9.34%	33.64%	-63.11%
Operating Cash Flow Q/Q Growth	53.93%	-31.01%	9.12%	13.55%	1.86%	25.17%	-18.57%	13.62%	10.76%	-5.81%
Free Cash Flow Firm Q/Q Growth	9.93%	-41.57%	-97.39%	-141.01%	225.25%	73.68%	-40.39%	-378.82%	40.90%	17.53%
Invested Capital Q/Q Growth	-12.63%	-3.17%	-10.28%	18.94%	-2.33%	-7.53%	0.30%	15.14%	5.06%	-6.67%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.64%	46.25%	46.21%	47.48%	24.01%	47.29%	50.03%	51.59%	51.05%	49.00%
EBITDA Margin	11.17%	14.39%	14.82%	16.33%	8.59%	15.41%	19.96%	19.86%	22.23%	11.61%
Operating Margin	8.97%	11.28%	12.43%	13.84%	7.26%	12.49%	17.09%	17.10%	14.74%	7.52%
EBIT Margin	7.88%	11.02%	11.20%	12.91%	6.76%	11.36%	16.28%	16.36%	18.36%	6.15%
Profit (Net Income) Margin	6.46%	9.59%	4.55%	9.55%	4.78%	8.12%	11.61%	11.80%	14.45%	3.38%
Tax Burden Percent	81.95%	86.99%	40.60%	73.97%	70.61%	71.48%	71.29%	72.12%	78.74%	55.00%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	18.05%	13.01%	59.40%	26.03%	29.39%	28.52%	28.71%	28.12%	21.63%	44.18%
Return on Invested Capital (ROIC)	20.59%	27.87%	13.56%	23.44%	21.11%	16.48%	25.21%	21.04%	17.51%	4.76%
ROIC Less NNEP Spread (ROIC-NNEP)	29.00%	30.38%	29.26%	557.82%	1.43%	3.14%	15.13%	17.66%	30.10%	2.73%
Return on Net Nonoperating Assets (RNNOA)	-6.65%	-6.20%	-2.30%	-1.65%	0.11%	0.40%	2.05%	5.89%	16.17%	2.29%
Return on Equity (ROE)	13.94%	21.67%	11.26%	21.79%	21.22%	16.88%	27.25%	26.93%	33.67%	7.05%
Cash Return on Invested Capital (CROIC)	37.63%	14.81%	-2.48%	-5.12%	9.17%	14.59%	11.19%	-9.72%	-8.11%	-46.47%
Operating Return on Assets (OROA)	7.12%	10.04%	10.53%	12.00%	11.44%	7.76%	11.75%	11.40%	13.84%	4.11%
Return on Assets (ROA)	5.84%	8.73%	4.27%	8.88%	8.08%	5.55%	8.38%	8.22%	10.90%	2.26%
Return on Common Equity (ROCE)	13.83%	21.46%	11.14%	21.28%	20.51%	16.49%	26.89%	26.54%	32.96%	6.90%
Return on Equity Simple (ROE_SIMPLE)	14.45%	22.51%	11.07%	20.19%	21.84%	16.79%	26.21%	26.80%	31.11%	6.39%
Net Operating Profit after Tax (NOPAT)	119	158	89	194	212	177	295	311	342	141
NOPAT Margin	7.35%	9.82%	5.05%	10.24%	5.13%	8.93%	12.19%	12.29%	11.55%	4.20%
Net Nonoperating Expense Percent (NNEP)	-8.41%	-2.51%	-15.70%	-534.38%	19.68%	13.34%	10.08%	3.38%	-12.60%	2.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	13.26%	12.80%	3.63%
Cost of Revenue to Revenue	56.36%	53.75%	53.79%	52.52%	51.98%	52.71%	49.97%	48.41%	48.95%	51.00%
SG&A Expenses to Revenue	24.15%	24.19%	23.51%	23.46%	12.07%	23.58%	23.21%	24.00%	24.60%	26.55%
R&D to Revenue	8.97%	9.18%	9.15%	9.15%	4.53%	9.96%	9.13%	9.32%	9.94%	11.18%
Operating Expenses to Revenue	34.67%	34.97%	33.78%	33.64%	33.50%	34.79%	32.93%	34.50%	36.31%	41.48%
Earnings before Interest and Taxes (EBIT)	128	178	198	245	280	226	394	414	544	207
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	181	232	262	310	356	306	483	503	659	391
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.42	4.82	7.20	5.11	8.54	8.54	11.80	8.97	7.36	4.99
Price to Tangible Book Value (P/TBV)	7.56	6.80	11.04	11.40	20.35	19.94	24.33	25.94	21.85	0.00
Price to Revenue (P/Rev)	2.43	2.05	2.96	2.42	1.87	4.13	5.22	3.95	3.42	2.64
Price to Earnings (P/E)	38.76	21.52	66.46	25.51	39.28	52.02	45.58	33.70	23.74	78.57
Dividend Yield	0.00%	0.78%	0.48%	0.55%	0.32%	0.30%	0.19%	0.29%	0.27%	0.34%
Earnings Yield	2.58%	4.65%	1.50%	3.92%	2.55%	1.92%	2.19%	2.97%	4.21%	1.27%
Enterprise Value to Invested Capital (EV/IC)	7.06	5.33	7.34	4.90	7.41	7.67	10.24	6.21	4.97	2.91
Enterprise Value to Revenue (EV/Rev)	2.30	2.00	2.95	2.44	1.91	4.19	5.30	4.18	3.70	3.22
Enterprise Value to EBITDA (EV/EBITDA)	20.64	13.90	19.90	14.96	22.21	27.22	26.54	21.06	16.64	27.72
Enterprise Value to EBIT (EV/EBIT)	29.24	18.15	26.33	18.93	28.20	36.91	32.55	25.58	20.16	52.35
Enterprise Value to NOPAT (EV/NOPAT)	31.34	20.38	58.45	23.87	37.21	46.96	43.48	34.04	32.04	76.66
Enterprise Value to Operating Cash Flow (EV/OCF)	16.33	24.64	33.73	19.33	37.05	25.09	45.37	38.58	31.33	43.10
Enterprise Value to Free Cash Flow (EV/FCFF)	17.15	38.35	0.00	0.00	85.68	53.06	97.91	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.36	0.59	0.57	0.37	0.87	0.87	1.23	1.08	0.91	1.15
Long-Term Debt to Equity	0.36	0.57	0.57	0.35	0.87	0.86	1.13	1.06	0.82	1.14
Financial Leverage	-0.23	-0.20	-0.08	0.00	0.08	0.13	0.14	0.33	0.54	0.84
Leverage Ratio	2.39	2.48	2.63	2.45	2.63	3.04	3.25	3.28	3.09	3.11
Compound Leverage Factor	2.39	2.48	2.63	2.45	2.63	3.04	3.25	3.28	3.09	3.11
Debt to Total Capital	26.61%	37.26%	36.17%	26.88%	46.43%	46.43%	55.16%	51.86%	47.55%	53.57%
Short-Term Debt to Total Capital	0.06%	1.82%	0.00%	1.46%	0.03%	0.12%	4.65%	0.80%	4.50%	0.83%
Long-Term Debt to Total Capital	26.55%	35.45%	36.17%	25.43%	46.41%	46.31%	50.51%	51.06%	43.06%	52.74%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.68%	0.61%	0.70%	2.45%	1.79%	0.72%	0.59%	0.77%	1.34%	0.87%
Common Equity to Total Capital	72.70%	62.13%	63.13%	70.67%	51.77%	52.85%	44.25%	47.38%	51.11%	45.56%
Debt to EBITDA	1.47	1.78	1.59	1.10	2.28	2.76	2.76	2.43	1.94	5.36
Net Debt to EBITDA	-1.12	-0.38	-0.09	0.06	0.36	0.37	0.34	1.14	1.20	4.89
Long-Term Debt to EBITDA	1.46	1.69	1.59	1.04	2.28	2.75	2.53	2.39	1.76	5.28
Debt to NOPAT	2.23	2.60	4.66	1.76	3.83	4.76	4.53	3.92	3.74	14.82
Net Debt to NOPAT	-1.70	-0.56	-0.26	0.10	0.60	0.64	0.56	1.84	2.32	13.52
Long-Term Debt to NOPAT	2.22	2.48	4.66	1.66	3.83	4.75	4.15	3.86	3.39	14.59
Altman Z-Score	4.64	4.18	5.01	4.68	5.51	4.36	5.11	4.64	4.30	2.77
Noncontrolling Interest Sharing Ratio	0.84%	0.95%	1.04%	2.36%	3.35%	2.33%	1.33%	1.46%	2.13%	2.17%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.22	2.43	2.59	2.18	2.78	2.43	2.63	2.31	1.80	1.60
Quick Ratio	1.27	1.42	1.45	1.13	1.62	1.35	1.69	1.22	0.82	0.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	218	84	-16	-42	92	157	131	-144	-159	-1,378
Operating Cash Flow to CapEx	688.29%	363.33%	479.50%	491.19%	344.19%	342.47%	324.23%	237.99%	365.45%	220.05%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.90	0.91	0.94	0.93	1.69	0.68	0.72	0.70	0.75	0.67
Accounts Receivable Turnover	6.15	6.73	6.27	5.60	11.52	5.70	6.43	5.69	6.15	6.37
Inventory Turnover	2.04	2.01	2.05	2.00	3.97	1.65	1.72	1.62	1.64	1.69
Fixed Asset Turnover	6.75	6.85	6.99	7.06	14.38	5.67	6.03	5.67	5.46	5.31
Accounts Payable Turnover	12.36	10.95	10.74	10.20	19.33	8.28	8.57	7.52	7.62	7.86
Days Sales Outstanding (DSO)	59.33	54.21	58.20	65.13	31.67	64.05	56.78	64.15	59.39	57.33
Days Inventory Outstanding (DIO)	179.35	181.74	178.02	182.54	92.05	221.14	211.82	224.99	222.39	216.43
Days Payable Outstanding (DPO)	29.53	33.34	33.99	35.80	18.88	44.07	42.59	48.54	47.93	46.43
Cash Conversion Cycle (CCC)	209.15	202.61	202.24	211.87	104.85	241.11	226.00	240.60	233.85	227.33
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	530	605	710	946	1,067	1,087	1,251	1,706	2,207	3,726
Invested Capital Turnover	2.80	2.84	2.69	2.29	4.12	1.85	2.07	1.71	1.52	1.13
Increase / (Decrease) in Invested Capital	-99	74	105	237	120	20	164	455	501	1,520
Enterprise Value (EV)	3,742	3,223	5,208	4,633	7,906	8,335	12,812	10,586	10,970	10,832
Market Capitalization	3,938	3,305	5,224	4,583	7,747	8,209	12,631	9,994	10,141	8,887
Book Value per Share	$4.33	$4.28	$4.66	$5.73	$5.89	$6.28	$7.06	$7.57	$9.95	$11.75
Tangible Book Value per Share	$3.10	$3.03	$3.04	$2.57	$2.47	$2.69	$3.42	$2.62	$3.35	($4.21)
Total Capital	999	1,105	1,149	1,269	1,752	1,819	2,419	2,351	2,695	3,910
Total Debt	266	412	416	341	813	845	1,334	1,219	1,282	2,094
Total Long-Term Debt	265	392	416	323	813	842	1,222	1,201	1,160	2,062
Net Debt	-203	-89	-24	19	128	113	166	574	793	1,911
Capital Expenditures (CapEx)	33	36	32	49	62	97	87	115	96	114
Debt-free, Cash-free Net Working Capital (DFCFNWC)	209	271	395	401	466	404	478	572	595	621
Debt-free Net Working Capital (DFNWC)	678	771	834	724	1,151	1,135	1,646	1,218	1,083	804
Net Working Capital (NWC)	677	751	834	705	1,151	1,133	1,533	1,199	962	772
Net Nonoperating Expense (NNE)	15	3.65	8.81	13	14	16	14	13	-86	27
Net Nonoperating Obligations (NNO)	-203	-89	-24	19	128	113	166	574	793	1,911
Total Depreciation and Amortization (D&A)	53	54	64	65	76	80	89	89	115	184
Debt-free, Cash-free Net Working Capital to Revenue	12.89%	16.82%	22.37%	21.16%	11.25%	20.30%	19.75%	22.61%	20.07%	18.45%
Debt-free Net Working Capital to Revenue	41.73%	47.87%	47.25%	38.17%	27.77%	57.12%	68.06%	48.11%	36.54%	23.90%
Net Working Capital to Revenue	41.69%	46.62%	47.25%	37.19%	27.76%	57.01%	63.41%	47.37%	32.45%	22.93%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.60	$0.95	$0.50	$1.15	$1.27	$1.03	$1.83	$2.00	$2.92	$0.76
Adjusted Weighted Average Basic Shares Outstanding	168.20M	161.40M	158.10M	156.20M	155.20M	153.40M	151.40M	148.60M	146.40M	149M
Adjusted Diluted Earnings per Share	$0.60	$0.95	$0.49	$1.14	$1.26	$1.02	$1.81	$1.99	$2.90	$0.76
Adjusted Weighted Average Diluted Shares Outstanding	169.10M	162.20M	159.10M	157.20M	156.60M	154.60M	152.90M	149.40M	147.20M	149.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$1.27	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	163.42M	159.88M	156.01M	156.74M	155.30M	151.57M	150.77M	146.73M	137.67M	151.71M
Normalized Net Operating Profit after Tax (NOPAT)	140	181	167	209	217	195	305	332	383	212
Normalized NOPAT Margin	8.62%	11.21%	9.48%	11.00%	5.24%	9.83%	12.61%	13.13%	12.93%	6.29%
Pre Tax Income Margin	7.88%	11.02%	11.20%	12.91%	6.76%	11.36%	16.28%	16.36%	18.36%	6.15%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	1.24%	17.15%	32.88%	14.36%	12.63%	15.99%	8.62%	13.94%	6.16%	39.46%
Augmented Payout Ratio	87.04%	120.71%	222.42%	14.36%	84.49%	92.32%	63.26%	102.08%	41.70%	39.46%

This table displays calculated financial ratios and metrics derived from Bruker's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.93%	3.64%	15.18%	15.89%	16.26%	20.62%	5.31%	17.42%	16.37%	14.64%
EBITDA Growth	14.73%	2.11%	13.83%	13.38%	-2.99%	91.20%	-19.29%	-33.17%	-27.09%	-60.82%
EBIT Growth	18.84%	1.26%	13.40%	11.35%	-7.81%	99.09%	-32.83%	-69.16%	-53.61%	-76.71%
NOPAT Growth	-2.40%	32.49%	38.48%	21.41%	3.21%	-17.13%	-46.90%	-75.50%	-45.98%	-77.40%
Net Income Growth	0.34%	29.34%	24.64%	16.30%	0.34%	108.14%	-32.82%	-86.85%	-54.57%	-93.21%
EPS Growth	3.51%	34.69%	26.83%	18.18%	1.69%	110.61%	-32.69%	-87.18%	-55.00%	-93.53%
Operating Cash Flow Growth	190.80%	23.74%	12.47%	129.28%	-36.55%	19.83%	-75.09%	-91.54%	-12.93%	-7.54%
Free Cash Flow Firm Growth	-821.42%	-315.28%	-92.68%	-58.83%	-263.81%	-18.45%	-44.55%	-350.33%	-249.85%	-262.76%
Invested Capital Growth	18.78%	36.35%	37.63%	32.94%	41.78%	29.38%	35.14%	97.45%	90.09%	68.87%
Revenue Q/Q Growth	8.58%	10.88%	-3.26%	-0.50%	8.93%	15.04%	-15.54%	10.95%	7.96%	13.33%
EBITDA Q/Q Growth	64.80%	-3.19%	-9.48%	-21.49%	41.01%	90.81%	-61.79%	-35.00%	53.84%	2.54%
EBIT Q/Q Growth	85.78%	-6.42%	-11.90%	-27.30%	53.81%	102.10%	-70.28%	-66.62%	131.38%	1.45%
NOPAT Q/Q Growth	69.53%	18.11%	-16.45%	-27.43%	44.12%	-5.17%	-46.46%	-66.52%	217.71%	-60.32%
Net Income Q/Q Growth	77.87%	11.20%	-21.26%	-25.32%	53.46%	130.67%	-74.58%	-85.38%	430.26%	-65.51%
EPS Q/Q Growth	78.79%	11.86%	-21.21%	-25.00%	53.85%	131.67%	-74.82%	-85.71%	440.00%	-66.67%
Operating Cash Flow Q/Q Growth	256.53%	146.76%	-48.98%	-85.14%	239.23%	365.99%	-89.39%	-94.95%	3,390.91%	394.79%
Free Cash Flow Firm Q/Q Growth	44.53%	-141.15%	-18.99%	0.21%	-27.06%	21.48%	-45.20%	-210.88%	1.29%	18.59%
Invested Capital Q/Q Growth	1.97%	15.14%	8.00%	4.84%	8.75%	5.06%	12.81%	53.19%	4.70%	-6.67%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	52.48%	51.65%	52.49%	49.93%	51.53%	50.36%	48.88%	48.03%	48.45%	50.36%
EBITDA Margin	23.52%	20.54%	19.22%	15.16%	19.63%	32.56%	14.73%	8.63%	12.30%	11.13%
Operating Margin	20.55%	18.49%	17.90%	12.64%	16.76%	12.11%	8.98%	6.01%	7.88%	7.36%
EBIT Margin	20.24%	17.08%	15.56%	11.37%	16.05%	28.19%	9.92%	2.98%	6.40%	5.73%
Profit (Net Income) Margin	13.84%	13.88%	11.29%	8.48%	11.94%	23.94%	7.21%	0.95%	4.66%	1.42%
Tax Burden Percent	68.37%	81.24%	72.61%	74.58%	74.41%	84.93%	72.63%	31.80%	72.88%	24.78%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	31.86%	19.34%	28.05%	25.68%	25.84%	15.40%	27.65%	67.36%	26.76%	72.55%
Return on Invested Capital (ROIC)	25.72%	25.54%	21.23%	15.07%	19.56%	15.53%	9.00%	2.13%	6.14%	2.29%
ROIC Less NNEP Spread (ROIC-NNEP)	25.41%	23.55%	18.90%	13.96%	19.04%	32.66%	9.61%	1.52%	5.50%	1.86%
Return on Net Nonoperating Assets (RNNOA)	8.51%	7.86%	7.83%	7.01%	11.98%	17.54%	6.03%	1.31%	5.36%	1.56%
Return on Equity (ROE)	34.24%	33.40%	29.06%	22.08%	31.55%	33.07%	15.03%	3.44%	11.50%	3.85%
Cash Return on Invested Capital (CROIC)	3.78%	-9.72%	-10.55%	-7.77%	-14.98%	-8.11%	-16.08%	-56.36%	-54.87%	-46.47%
Operating Return on Assets (OROA)	15.69%	11.91%	11.15%	8.52%	12.64%	21.26%	7.20%	1.91%	4.18%	3.83%
Return on Assets (ROA)	10.73%	9.67%	8.09%	6.35%	9.41%	18.06%	5.23%	0.61%	3.04%	0.95%
Return on Common Equity (ROCE)	33.72%	32.91%	28.39%	21.57%	30.80%	32.37%	14.66%	3.36%	11.23%	3.76%
Return on Equity Simple (ROE_SIMPLE)	29.48%	0.00%	26.59%	26.15%	26.65%	0.00%	28.48%	19.72%	16.85%	0.00%
Net Operating Profit after Tax (NOPAT)	89	106	88	64	92	88	47	16	50	20
NOPAT Margin	14.00%	14.92%	12.88%	9.40%	12.43%	10.25%	6.50%	1.96%	5.77%	2.02%
Net Nonoperating Expense Percent (NNEP)	0.31%	1.99%	2.34%	1.11%	0.52%	-17.12%	-0.61%	0.61%	0.64%	0.44%
Return On Investment Capital (ROIC_SIMPLE)	-	4.51%	-	-	-	3.27%	-	-	-	0.51%
Cost of Revenue to Revenue	47.52%	48.35%	47.51%	50.07%	48.47%	49.64%	51.12%	51.97%	51.55%	49.64%
SG&A Expenses to Revenue	22.66%	23.25%	23.74%	26.09%	23.91%	24.72%	27.06%	27.64%	26.60%	25.25%
R&D to Revenue	8.80%	8.96%	10.07%	10.41%	9.60%	9.77%	11.33%	11.51%	11.35%	10.66%
Operating Expenses to Revenue	31.93%	33.16%	34.58%	37.29%	34.77%	38.24%	39.91%	42.03%	40.57%	43.00%
Earnings before Interest and Taxes (EBIT)	129	121	107	78	119	241	72	24	55	56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	150	146	132	103	146	278	106	69	106	109
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.35	8.97	9.77	8.78	7.55	7.36	9.13	5.18	5.79	4.99
Price to Tangible Book Value (P/TBV)	22.90	25.94	32.52	29.00	25.64	21.85	60.33	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.12	3.95	4.40	3.98	3.24	3.42	4.31	2.97	3.23	2.64
Price to Earnings (P/E)	28.45	33.70	37.00	33.89	28.59	23.74	32.18	26.34	34.29	78.57
Dividend Yield	0.36%	0.29%	0.25%	0.27%	0.32%	0.27%	0.21%	0.31%	0.29%	0.34%
Earnings Yield	3.52%	2.97%	2.70%	2.95%	3.50%	4.21%	3.11%	3.80%	2.92%	1.27%
Enterprise Value to Invested Capital (EV/IC)	5.65	6.21	6.62	5.96	4.77	4.97	5.62	2.96	3.17	2.91
Enterprise Value to Revenue (EV/Rev)	3.34	4.18	4.65	4.24	3.55	3.70	4.66	3.62	3.90	3.22
Enterprise Value to EBITDA (EV/EBITDA)	16.74	21.06	23.50	21.69	19.02	16.64	22.09	18.85	22.58	27.72
Enterprise Value to EBIT (EV/EBIT)	20.28	25.58	28.58	26.51	23.60	20.16	27.49	24.80	32.27	52.35
Enterprise Value to NOPAT (EV/NOPAT)	29.27	34.04	36.30	33.17	28.57	32.04	46.83	42.92	57.27	76.66
Enterprise Value to Operating Cash Flow (EV/OCF)	34.64	38.58	42.90	33.72	31.68	31.33	49.22	41.46	47.38	43.10
Enterprise Value to Free Cash Flow (EV/FCFF)	162.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.21	1.08	1.02	0.98	0.98	0.91	0.95	1.18	1.25	1.15
Long-Term Debt to Equity	1.19	1.06	0.92	0.89	0.88	0.82	0.94	1.17	1.23	1.14
Financial Leverage	0.34	0.33	0.41	0.50	0.63	0.54	0.63	0.86	0.97	0.84
Leverage Ratio	3.16	3.28	3.25	3.21	3.26	3.09	3.11	3.16	3.22	3.11
Compound Leverage Factor	3.16	3.28	3.25	3.21	3.26	3.09	3.11	3.16	3.22	3.11
Debt to Total Capital	54.75%	51.86%	50.38%	49.62%	49.50%	47.55%	48.72%	54.19%	55.49%	53.57%
Short-Term Debt to Total Capital	0.81%	0.80%	4.92%	4.82%	4.91%	4.50%	0.75%	0.66%	0.79%	0.83%
Long-Term Debt to Total Capital	53.94%	51.06%	45.45%	44.79%	44.59%	43.06%	47.97%	53.53%	54.69%	52.74%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.79%	0.77%	1.25%	1.25%	1.44%	1.34%	1.25%	0.89%	0.87%	0.87%
Common Equity to Total Capital	44.46%	47.38%	48.37%	49.13%	49.06%	51.11%	50.02%	44.92%	43.64%	45.56%
Debt to EBITDA	2.31	2.43	2.37	2.34	2.32	1.94	2.18	3.60	4.10	5.36
Net Debt to EBITDA	1.06	1.14	1.22	1.26	1.63	1.20	1.64	3.32	3.84	4.89
Long-Term Debt to EBITDA	2.28	2.39	2.14	2.11	2.09	1.76	2.14	3.56	4.04	5.28
Debt to NOPAT	4.04	3.92	3.66	3.58	3.48	3.74	4.61	8.20	10.41	14.82
Net Debt to NOPAT	1.85	1.84	1.88	1.93	2.44	2.32	3.47	7.55	9.74	13.52
Long-Term Debt to NOPAT	3.98	3.86	3.30	3.23	3.13	3.39	4.54	8.10	10.26	14.59
Altman Z-Score	3.27	4.37	3.84	3.62	3.27	4.07	4.25	2.64	2.75	2.69
Noncontrolling Interest Sharing Ratio	1.52%	1.46%	2.29%	2.29%	2.37%	2.13%	2.48%	2.16%	2.32%	2.17%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.36	2.31	2.03	2.08	1.89	1.80	1.81	1.65	1.66	1.60
Quick Ratio	1.21	1.22	1.02	0.98	0.79	0.82	0.69	0.52	0.52	0.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-145	-349	-415	-414	-527	-413	-600	-1,866	-1,842	-1,500
Operating Cash Flow to CapEx	120.45%	497.10%	611.89%	55.32%	165.17%	656.55%	104.31%	4.55%	117.79%	520.55%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.78	0.70	0.72	0.75	0.79	0.75	0.73	0.64	0.65	0.67
Accounts Receivable Turnover	6.32	5.69	5.92	6.36	6.22	6.15	6.34	6.51	6.33	6.37
Inventory Turnover	1.65	1.62	1.58	1.57	1.64	1.64	1.56	1.50	1.55	1.69
Fixed Asset Turnover	6.18	5.67	5.73	5.92	5.94	5.46	5.47	5.29	5.31	5.31
Accounts Payable Turnover	8.20	7.52	7.06	7.64	8.07	7.62	7.56	7.67	8.09	7.86
Days Sales Outstanding (DSO)	57.78	64.15	61.66	57.38	58.71	59.39	57.60	56.04	57.64	57.33
Days Inventory Outstanding (DIO)	220.94	224.99	231.21	232.60	221.95	222.39	234.37	243.13	235.61	216.43
Days Payable Outstanding (DPO)	44.54	48.54	51.69	47.77	45.20	47.93	48.27	47.58	45.11	46.43
Cash Conversion Cycle (CCC)	234.19	240.60	241.18	242.21	235.45	233.85	243.70	251.59	248.15	227.33
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,481	1,706	1,842	1,931	2,100	2,207	2,489	3,813	3,992	3,726
Invested Capital Turnover	1.84	1.71	1.65	1.60	1.57	1.52	1.39	1.09	1.06	1.13
Increase / (Decrease) in Invested Capital	234	455	504	479	619	501	647	1,882	1,892	1,520
Enterprise Value (EV)	8,365	10,586	12,189	11,515	10,014	10,970	13,997	11,298	12,641	10,832
Market Capitalization	7,821	9,994	11,527	10,815	9,123	10,141	12,923	9,274	10,455	8,887
Book Value per Share	$6.33	$7.57	$8.04	$8.39	$8.23	$9.95	$10.28	$12.31	$11.94	$11.75
Tangible Book Value per Share	$2.31	$2.62	$2.42	$2.54	$2.42	$3.35	$1.56	($4.67)	($4.58)	($4.21)
Total Capital	2,108	2,351	2,440	2,506	2,464	2,695	2,829	3,983	4,140	3,910
Total Debt	1,154	1,219	1,229	1,243	1,220	1,282	1,379	2,158	2,297	2,094
Total Long-Term Debt	1,137	1,201	1,109	1,123	1,099	1,160	1,357	2,132	2,265	2,062
Net Debt	528	574	631	669	856	793	1,038	1,989	2,149	1,911
Capital Expenditures (CapEx)	58	35	14	24	27	31	21	24	33	37
Debt-free, Cash-free Net Working Capital (DFCFNWC)	563	572	607	679	715	595	639	705	754	621
Debt-free Net Working Capital (DFNWC)	1,189	1,218	1,205	1,253	1,078	1,083	979	875	902	804
Net Working Capital (NWC)	1,172	1,199	1,085	1,132	957	962	958	849	869	772
Net Nonoperating Expense (NNE)	1.06	7.37	11	6.27	3.63	-117	-5.12	8.10	9.57	5.89
Net Nonoperating Obligations (NNO)	528	574	631	669	856	793	1,038	1,989	2,149	1,911
Total Depreciation and Amortization (D&A)	21	25	25	26	27	37	35	45	51	53
Debt-free, Cash-free Net Working Capital to Revenue	22.46%	22.61%	23.15%	25.00%	25.35%	20.07%	21.29%	22.60%	23.26%	18.45%
Debt-free Net Working Capital to Revenue	47.45%	48.11%	45.96%	46.17%	38.25%	36.54%	32.63%	28.04%	27.83%	23.90%
Net Working Capital to Revenue	46.77%	47.37%	41.38%	41.72%	33.96%	32.45%	31.92%	27.20%	26.82%	22.93%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.60	$0.66	$0.52	$0.39	$0.60	$1.41	$0.35	$0.05	$0.27	$0.09
Adjusted Weighted Average Basic Shares Outstanding	147.80M	148.60M	146.80M	146.80M	146.60M	146.40M	145.20M	147.40M	151.50M	149M
Adjusted Diluted Earnings per Share	$0.59	$0.66	$0.52	$0.39	$0.60	$1.39	$0.35	$0.05	$0.27	$0.09
Adjusted Weighted Average Diluted Shares Outstanding	148.60M	149.40M	147.60M	147.70M	147.30M	147.20M	145.90M	148M	152M	149.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	147.08M	146.73M	146.73M	146.85M	138.41M	137.67M	145.34M	151.39M	151.60M	151.71M
Normalized Net Operating Profit after Tax (NOPAT)	92	111	92	68	99	115	55	50	66	99
Normalized NOPAT Margin	14.32%	15.68%	13.44%	9.98%	13.37%	13.43%	7.59%	6.22%	7.69%	10.12%
Pre Tax Income Margin	20.24%	17.08%	15.56%	11.37%	16.05%	28.19%	9.92%	2.98%	6.40%	5.73%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	14.12%	13.94%	11.54%	8.98%	8.44%	6.16%	8.06%	9.27%	10.31%	39.46%
Augmented Payout Ratio	129.62%	102.08%	68.87%	46.13%	48.23%	41.70%	40.29%	46.08%	26.86%	39.46%

Frequently Asked Questions About Bruker's Financials

When does Bruker's fiscal year end?

According to the most recent income statement we have on file, Bruker's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Bruker's net income changed over the last 9 years?

Bruker's net income appears to be on an upward trend, with a most recent value of $113.80 million in 2024, rising from $104.90 million in 2015. The previous period was $428.50 million in 2023.

What is Bruker's operating income?

Bruker's total operating income in 2024 was $253.10 million, based on the following breakdown:

Total Gross Profit: $1.65 billion
Total Operating Expenses: $1.40 billion

How has Bruker revenue changed over the last 9 years?

Over the last 9 years, Bruker's total revenue changed from $1.62 billion in 2015 to $3.37 billion in 2024, a change of 107.3%.

How much debt does Bruker have?

Bruker's total liabilities were at $3.99 billion at the end of 2024, a 40.7% increase from 2023, and a 300.3% increase since 2015.

How much cash does Bruker have?

In the past 9 years, Bruker's cash and equivalents has ranged from $183.40 million in 2024 to $1.07 billion in 2021, and is currently $183.40 million as of their latest financial filing in 2024.

How has Bruker's book value per share changed over the last 9 years?

Over the last 9 years, Bruker's book value per share changed from 4.33 in 2015 to 11.75 in 2024, a change of 171.7%.

Remove Ads

Related Companies

This page (NASDAQ:BRKR) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bruker (BRKR) Financials

Frequently Asked Questions About Bruker's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bruker (BRKR) Financials

Annual Income Statements for Bruker

Quarterly Income Statements for Bruker

Annual Cash Flow Statements for Bruker

Quarterly Cash Flow Statements for Bruker

Annual Balance Sheets for Bruker

Quarterly Balance Sheets for Bruker

Annual Metrics and Ratios for Bruker

Quarterly Metrics and Ratios for Bruker

Frequently Asked Questions About Bruker's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools